Relapse of Ulcerative Colitis on Dose Reduction of Tofacitinib is Associated with Markers of T-cell Activation but Not Clinical Features: a Prospective, Multicentre Observational Study
JOURNAL OF CROHNS & COLITIS(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined